Z-138: A new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia

Leukemia Research

Volumn 22, Issue 4, 1998, Pages 341-353

  Estrov, Z ^a   Talpaz, M ^a   Ku, S ^a   Harris, D ^a   Van, Q ^a   Beran, M ^a   Hirsch Ginsberg, C ^a   Huh, Y ^a   Yee, G ^a   Kurzrock, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute lymphoblastic leukemia; Cell line; Chronic lymphocytic leukemia

Indexed keywords

CYCLIN D1; GLUCOSE REGULATED PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; GENE REARRANGEMENT; HUMAN; LEUKEMIA CELL LINE; LYMPHOBLAST; LYMPHOCYTE TRANSFORMATION; MALE; PRIORITY JOURNAL;

AGED; BLOTTING, SOUTHERN; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 9; CLONE CELLS; DNA; FUSION PROTEINS, BCR-ABL; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN J-CHAINS; IMMUNOPHENOTYPING; INTERLEUKIN-1; INTERLEUKIN-6; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTE ACTIVATION; MALE; MICROSCOPY, ELECTRON; RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17144453582     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00191-4     Document Type: Article

References (63)

1. [1] Foon KA, Thiruvengadam R, Saven A, Bernstein ZP, Gale RP. Genetic relatedness of lymphoid malignancies: transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993;119:63-73.
2. [2] Zarrabi MH, Grunwald HW, Rosner F. Chronic lymphocytic leukemia terminating in acute leukemia. Arch Intern Med 1977;137:1059-64.
3. [3] Frankel EP, Ligler FS, Graham MS, Hernandez JA, Kettman JR, Smith RG. Acute lymphocytic leukemia transformation of chronic lymphocytic leukemia. A substantiation by flow cytometry. Am J Hematol 1981;10:391-8.
4. [4] Stern N, Shemesh J, Ramot B. Chronic lymphatic leukemia terminating in acute myeloid leukemia: review of the literature. Cancer 1981;47:1849-51.
5. [5] Eridani S, Parry H, Glass U, Greaves M. Acute lymphoblastic leukemia supervening in a case of chronic lymphocytic leukemia after continuous 3-year treatment with chlorambucil. Cancer 1984;54:397-9.
6. [6] Hammami A, Chan WC, Michels SD, Nassar VH. Mature B-cell acute leukemia: a clinical, morphological, immunological and cytogenetic study of nine cases. Hematol Pathol 1991;5:109-18.
7. [7] Graham RC, Karnovsky MJ. The early stages of absorption of injected horseradish peroxidase in proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 1966;14:291-302.
8. [8] LeMaistre A, Childs C, Hirsch-Ginsberg C, Reuben J, Cork A, Trujillo J, Anderson B, McCredie K, Freireich E, Stass S. Heterogeneity in acute undifferentiated leukemia. Hematol Pathol 1988;2:79-90.
9. [9] Griffin JD. The use of monoclonal antibodies in the characterization of myeloid leukemias. Hematol Pathol 1987;1:81-91.
10. [10] Seabright M. A rapid banding technique for human chromosomes. Lancet 1971;2:971.
11. [11] Bergsma D, Lindsten JE, Klinger HP, Hamerton JL. An international system for human cytogenetic nomenclature: Report of the Standing Committee on Human Cytogenetic Nomenclature. Cytogenet Cell Genet 1978;21:309-402.
12. [12] Kurzrock R, Ku S, Talpaz M. Abnormalities in the PRAD1 (CYCLIN Dl/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 1995;75:584-90.
13. [13] Kloetzer W, Kurzrock R, Smith L, Talpaz M, Spiller M, Gutterman JU, Arlinghaus R. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology 1985;140:230-8.
14. bcr-abl in chronic myelogenous leukemia. Blood 1987;70:233-6.
15. [15] Kurzrock R, Blick MB, Talpaz M, Velasquez WS, Trujillo JM, Kouttab NM, Kloetzer WS, Arlinghaus RB, Gutterman JU. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia. Ann Intern Med 1986;105:673-9.
16. [16] Hearing JC, Nicolas J-C, Levine AJ. Identification of Epstein -Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes. Proc Natl Acad Sci USA 1984;81:4373-7.
17. [17] Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a BCL1-linked candidate oncogene. Nature 1991;350:512-5.
18. [18] Tsujimoto Y, Jaffe E, Cossman J, Graham J, Nowell PC, Croce CM. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985;315:340-3.
19. [19] Tsujimoto Y, Louie E, Bashin MM, Croce CM. The receprocal partners of both the t(14;18) and the t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 1988;2:347-51.
20. [20] Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-17.
21. [21] Feinberg AD, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984;137:226-67.
22. [22] Thomas PS. Hybridization of denaturated RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980;77:5201-5.
23. [23] Sambrook J, Frisch EF, Maniatis T. Molecular cloning. A laboratory manual. In: Ford N, Nolan C, Ferguson M, editors. In Vitro Amplification of DNA by the Polymerase Chain Reaction. New York: Spring Harbor Press, 1989:14.1-14.35.
24. [24] Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Suppression of chronic myelogenous leukemia colony growth by IL-1 receptor antagonist and soluble IL-1 receptors: novel application for inhibitors of IL-1 activity. Blood 1991;78:1476-84.
25. [25] Estrov Z, Cohen A, Gelfand EW, Freedman MH. Synergistic antiproliferative effects on HL-60 cells: Deferoxamine enhances cytosine arabinoside, methotrexate and daunorubicin cytotoxicity. J Pediatr Hematol Oncol 1988;10:288-91.
26. [26] Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Guttermann JU, Talpaz M. Inhibition of acute myelogenous leukemia blast proliferation by IL-1 receptor antagonist and soluble IL-1 receptors. Blood 1992;79:1938-45.
27. [27] Ferrajoli A, Zipf TF, Talpaz M, Felix EA, Estrov Z. Growth factors controlling interleukin-4 action on hematopoietic progenitors. Ann Hematol 1993;67:277-84.
28. [28] Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of the acute leukemias. Br J Haematol 1976;33:451-8.
29. [29] Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988;319:990-8.
30. 1-positive cell lines (Z-119 and Z-181). J Cell Physiol 1996;166:618-30.
31. [31] Cohen A, Grunberger T, Vanek W, Dube ID, Doherty PJ, Letarte M, Roifman C, Freedman MH. Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemia cell line. Blood 1991;78:94-102.
32. [32] Freedman MH, Grunberger T, Correa P, Axelrad AA, Dube ID, Cohen A. Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells. Blood 1993;81:3068-75.
33. [33] Robertson LE, Pough W, O'Brien S, Kantarjian H, Hirsch-Ginsberg C, Cork A, McLaughlin P, Cabanillas F, Keating M. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993;11:1985-9.
34. [34] Mohamed AN, Compean R, Dan ME, Smith MR, Al-Katib A. Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996;86:143-6.
35. [35] Torelli UL, Torelli GM, Emilia G, Selleri L, Venturelli D, Artusi T, Donelli A, Collo A, Fornieri C. Simultaneously increased expression of the c-myc and m chain genes in the acute blastic transformation of chronic lymphocytic leukemia. Br J Haematol 1987;65:165-70.
36. [36] Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
37. [37] Yunis JJ, Okem MM, Kaplan ME, Ensrud KM, Howe RR, Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982;307:1231-6.
38. [38] Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ. Expression of bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987;80:1512-5.
39. [39] Seto M, Jaeger U, Hockett RD, Graninger W, Bennet S, Goldman P, Korsmeyer SJ. Alternative promoters and exons, somatic mutation and deregulation of bcl-2-Ig fusion gene in lymphoma. EMBO J 1988;7:123-31.
40. [40] Korsmeyer SJ. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Ann Rev Immunol 1992;10:785-807.
41. [41] Nunez G, Merino R, Grillot D, Gonzalez-Garcia M. Bcl-2 and bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 1994;15:582-7.
42. [42] Reed JC. Cellular mechanisms of disease series: bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
43. [43] Oltvai ZN, Kosmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-92.
44. [44] Fifth International Workshop on Chromosomes in Leukemia Lymphoma: correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T cell leukemia lymphoma. Blood 1987;70:1554.
45. [45] Offit K, Jhnwar SC, Ladanyi M, Filippa DA, Chaganti RSK. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma. Correlations between recurrent abberations, histology and exposure to cytotoxic treatment. Genes Chromosomes Cancer 1991;3:189.
46. [46] Hluska FG, Tsujimoto Y, Croce CM. Oncogene activation by chromosome translocation in human malignancy. Ann Rev Genet 1987;21:321.
47. [47] Ladanyi M, Offit K, Jhnwar SC. Filippa DA, Chaganti RSK. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphoma. Blood 1991;77:1057.
48. [48] Ryan KM, Birnie GD. Myc oncogene: the enigmatic family. Biochem J 1996;314:713-21.
49. [49] Tsujimoto Y, Yunis J, Onorato-Showe L, Erickson J, Nowell P, Croce C. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984;224:1403-6.
50. [50] Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell P, Croce C. Clustering of the breakpoints on chromosome 11 in human B-cell neoplasms with t(11;14) chromosome translocation. Nature 1986;315:340-3.
51. [51] Kluin PM, Van Krieken JHJM. The molecular biology of B-cell lymphomas: clinicopathlogic implications. Ann Hematol 1991;62:95-102.
52. [52] Swerdlow SH, Yang WI, Zukerberg LR, Harris NL, Arnold A, Williams ME. Expression of cyclin D1 protein in centro-cytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 1995;26:999-1004.
53. [53] Raffeld M, Jaffe ES. Bcl-1, t(11;14) and mantle cell-derived lymphoma. Blood 1991;78:259-63.
54. [54] Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 1991;78:493-8.
55. [55] Tsuchiya H, Adachi N, Asou N, Takatsuki K, Matsuda I, Kawano F, Murakami T, Mizutani S, Watanabe M. Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Philadelphia-positive acute lymphoblastic leukemia with myeloid surface markers. Blood 1991;77:411-3.
56. [56] Estrov Z, Freedman MH. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay. Cancer Res 1988;48:5901-7.
57. [57] Drach D, Estrov Z, Zhao S, Drach J, Cork A, Collins D, Kantarjian H, Andreeff M. G-CSF, GM-CSF, SCF, PIXY 321, IL-3 and IL-7: receptor binding and effects on clonogenic growth in acute lymphoblastic leukemia. Leuk Lymphoma 1994;16:79-88.
58. [58] Estrov Z, Talpaz M, Ku S, Harris D, LaPushin R, Koller CA, Hircsh-Ginsberg C, Huh Y, Yee G, Kurzrock R. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. Leukemia 1996;10:1534-43.
59. [59] Touw J, Pouweis K, Van Agthoven T, Van Gurp R, Budel L, Hoogerbrugge H, Delwel R, Goodwin R, Namen A, Lowenberg B. Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 1990;75:2097-101.
60. [60] Kawano M, Hirano T, Matsuda T. Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T. Autocrine generation and requirement of BSF-2/ IL-6 for human multiple myelomas. Nature 1988;332:83-5.
61. [61] Estrov Z, Kurzrock R, Talpaz M. Interruption of endogenous growth regulatory networks: a novel approach to inhibition of leukemia cell proliferation. Forum Trends Exp Clin Med 1993;3:306-18.
62. [62] Morikawa K, Morikawa S, Miyawaki T, Nagasaki M, Torii I, Imai K. Constitutive expression of granulocyte-colony stimulating factor receptor on a human B-lymphoblastoid cell line. Br J Haematol 1996;94:250-7.
63. [63] Tsuchiya H, El-Sonbaty SS, Watanabe M, Suzushina H, Adou N, Murakami T, Takeda T, Shimosaka A, Taketsuki K, Matsuda I. Analysis of myeloid characteristics in acute lymphoblastic leukemia. Leuk Res 1993;17:809-13.